€57,48 €47,50 hors TVA
Gangliosidosis (GM2 Type II-1), also known as Sanddhoff disease and GM2 gangliosidosis variant 0, is a lysosomal storage disease in which there is a buildup of GM2 gangliosides (a type of glycolipid) in various tissues.
10 working days
Excl €5,95 shipping and administration per order (incl. VAT)
Caractéristiques
| Breeds | |
|---|---|
| Gene | |
| Chromosome | A1 |
| Mutation | c.39delC |
| Mode of Inheritance | Autosomique récessif |
| Organ | |
| Specimen | Écouvillonnage, sanguin EDTA, sanguine hépariné, sperme, tissu |
| Also known as | GM2, variant 0; Sandhoff |
Informations générales
Gangliosidosis (GM2 Type II-1), also known as Sanddhoff disease and GM2 gangliosidosis variant 0, is a lysosomal storage disease in which there is a buildup of GM2 gangliosides (a type of glycolipid) in various tissues.
This variant is for the Korat cat breed.
Caractéristiques cliniques
Cats affected with GM2 show progressive neuromuscular dysfunction and impaired growth from an early age. Affected kittens have head tremors at the beginning followed by impaired coordination of leg movements which eventually lead to paralysis.
Additional Information
Références
Pubmed ID: 8178934
Year published: 1994
Omia ID: 1462
Omia variant ID: 497